Found: 15
Select item for more details and to access through your institution.
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.682445
- By:
- Publication type:
- Article
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10911-5
- By:
- Publication type:
- Article
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211049779
- By:
- Publication type:
- Article
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211049779
- By:
- Publication type:
- Article
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920975326
- By:
- Publication type:
- Article
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.946319
- By:
- Publication type:
- Article
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.827822
- By:
- Publication type:
- Article
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184344
- By:
- Publication type:
- Article
Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2118, doi. 10.3390/cancers13092118
- By:
- Publication type:
- Article
A "Lymphocyte MicroRNA Signature" as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3396, doi. 10.3390/cancers12113396
- By:
- Publication type:
- Article
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2415, doi. 10.3390/cancers12092415
- By:
- Publication type:
- Article
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells.
- Published in:
- Journal of Cellular & Molecular Medicine, 2012, v. 16, n. 9, p. 2186, doi. 10.1111/j.1582-4934.2012.01527.x
- By:
- Publication type:
- Article
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells.
- Published in:
- Journal of Cellular Physiology, 2013, v. 228, n. 6, p. 1368, doi. 10.1002/jcp.24295
- By:
- Publication type:
- Article
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1414343
- By:
- Publication type:
- Article